Medicine

UK approves Leqembi, but reimbursement may not follow

Posted on by admin

Leqembi’s benefits are “too small to justify the significant cost to the NHS,” said the head of a UK agency in charge of determining medicine reimbursement.

Leave a Reply

Your email address will not be published. Required fields are marked *